Introduction
Myocardial Infarction - Overview
Myocardial Infarction - Therapeutics Development
Myocardial Infarction - Therapeutics Assessment
Myocardial Infarction - Companies Involved in Therapeutics Development
Myocardial Infarction - Drug Profiles
Myocardial Infarction - Dormant Projects
Myocardial Infarction - Discontinued Products
Myocardial Infarction - Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Myocardial Infarction, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..2), H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..3), H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..4), H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020 (Contd..1), H1 2020
Products under Development by Companies, H1 2020
Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Products under Development by Companies, H1 2020 (Contd..2), H1 2020
Products under Development by Companies, H1 2020 (Contd..3), H1 2020
Products under Development by Companies, H1 2020 (Contd..4), H1 2020
Products under Development by Companies, H1 2020 (Contd..5), H1 2020
Products under Development by Universities/Institutes, H1 2020
Products under Development by Universities/Institutes, H1 2020 (Contd..1), H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Target, H1 2020 (Contd..1), H1 2020
Number of Products by Stage and Target, H1 2020 (Contd..2), H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020 (Contd..1), H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020 (Contd..2), H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Myocardial Infarction - Pipeline by Actinogen Medical Ltd, H1 2020
Myocardial Infarction - Pipeline by Angion Biomedica Corp, H1 2020
Myocardial Infarction - Pipeline by Ankasa Regenerative Therapeutics Inc, H1 2020
Myocardial Infarction - Pipeline by Aposcience AG, H1 2020
Myocardial Infarction - Pipeline by Applied Therapeutics Inc, H1 2020
Myocardial Infarction - Pipeline by Aprogen Inc, H1 2020
Myocardial Infarction - Pipeline by APT Therapeutics Inc, H1 2020
Myocardial Infarction - Pipeline by AstraZeneca Plc, H1 2020
Myocardial Infarction - Pipeline by Athera Biotechnologies AB, H1 2020
Myocardial Infarction - Pipeline by Athersys Inc, H1 2020
Myocardial Infarction - Pipeline by Axolo Pharma Inc, H1 2020
Myocardial Infarction - Pipeline by Bayer AG, H1 2020
Myocardial Infarction - Pipeline by Bharat Biotech Ltd, H1 2020
Myocardial Infarction - Pipeline by Cadila Healthcare Ltd, H1 2020
Myocardial Infarction - Pipeline by CardioCreate Inc, H1 2020
Myocardial Infarction - Pipeline by Cardiol Therapeutics Inc, H1 2020
Myocardial Infarction - Pipeline by Cardior Pharmaceuticals GmbH, H1 2020
Myocardial Infarction - Pipeline by CeleCor Therapeutics Inc, H1 2020
Myocardial Infarction - Pipeline by Celixir Ltd, H1 2020
Myocardial Infarction - Pipeline by CellProthera SAS, H1 2020
Myocardial Infarction - Pipeline by CFM Pharma Holding BV, H1 2020
Myocardial Infarction - Pipeline by Cynata Therapeutics Ltd, H1 2020
Myocardial Infarction - Pipeline by Diffusion Pharmaceuticals Inc, H1 2020
Myocardial Infarction - Pipeline by Domainex Ltd, H1 2020
Myocardial Infarction - Pipeline by EndoProtech Inc, H1 2020
Myocardial Infarction - Pipeline by Ever Supreme Bio Technology Co Ltd, H1 2020
Myocardial Infarction - Pipeline by Evotec SE, H1 2020
Myocardial Infarction - Pipeline by EyeGene Inc, H1 2020
Myocardial Infarction - Pipeline by Faraday Pharmaceuticals Inc, H1 2020
Myocardial Infarction - Pipeline by General Regeneratives Shanghai Ltd, H1 2020
Myocardial Infarction - Pipeline by Generium, H1 2020
Myocardial Infarction - Pipeline by GNT Pharma Co Ltd, H1 2020
Myocardial Infarction - Pipeline by Hemostemix Inc, H1 2020
Myocardial Infarction - Pipeline by Honya Medical Inc, H1 2020
Myocardial Infarction - Pipeline by HUYA Bioscience International LLC, H1 2020
Myocardial Infarction - Pipeline by Idorsia Pharmaceutical Ltd, H1 2020
Myocardial Infarction - Pipeline by iHeart Japan Corp, H1 2020
Myocardial Infarction - Pipeline by InCarda Therapeutics Inc, H1 2020
Myocardial Infarction - Pipeline by Innolife Co Ltd, H1 2020
Myocardial Infarction - Pipeline by Inotrem SA, H1 2020
Myocardial Infarction - Pipeline by IPS Heart Inc, H1 2020
Myocardial Infarction - Pipeline by K-Stemcell Co Ltd, H1 2020
Myocardial Infarction - Pipeline by Kine Sciences, H1 2020
Myocardial Infarction - Pipeline by Lee’s Pharmaceutical Holdings Ltd, H1 2020
Myocardial Infarction - Pipeline by LTT Bio-Pharma Co Ltd, H1 2020
Myocardial Infarction - Pipeline by MandalMed Inc, H1 2020
Myocardial Infarction - Pipeline by Marizyme Inc, H1 2020
Myocardial Infarction - Pipeline by Mesoblast Ltd, H1 2020
Myocardial Infarction - Pipeline by MIFCOR Inc, H1 2020
Myocardial Infarction - Pipeline by MimeTech Srl, H1 2020
Myocardial Infarction - Pipeline by Mirae Cell Bio Co Ltd, H1 2020
Myocardial Infarction - Pipeline by New World Laboratories Inc, H1 2020
Myocardial Infarction - Pipeline by Novartis AG, H1 2020
Myocardial Infarction - Pipeline by NuvOx Pharma LLC, H1 2020
Myocardial Infarction - Pipeline by OMEICOS Therapeutics GmbH, H1 2020
Myocardial Infarction - Pipeline by OP2 Drugs SAS, H1 2020
Myocardial Infarction - Pipeline by Opsona Therapeutics Ltd, H1 2020
Myocardial Infarction - Pipeline by OtiTopic LLC, H1 2020
Myocardial Infarction - Pipeline by Oxstem Ltd, H1 2020
Myocardial Infarction - Pipeline by Pharmahungary Group, H1 2020
Myocardial Infarction - Pipeline by Polyphor AG, H1 2020
Myocardial Infarction - Pipeline by Primary Peptides Inc, H1 2020
Myocardial Infarction - Pipeline by Quark Pharmaceuticals Inc, H1 2020
Myocardial Infarction - Pipeline by Qurgen Inc (Inactive), H1 2020
Myocardial Infarction - Pipeline by Reata Pharmaceuticals Inc, H1 2020
Myocardial Infarction - Pipeline by Recardio GmbH, H1 2020
Myocardial Infarction - Pipeline by RegeneRx Biopharmaceuticals Inc, H1 2020
Myocardial Infarction - Pipeline by ResoTher Pharma ApS, H1 2020
Myocardial Infarction - Pipeline by Rubicon Biotechnology Inc, H1 2020
Myocardial Infarction - Pipeline by Sentan Pharma Inc, H1 2020
Myocardial Infarction - Pipeline by Serpin Pharma LLC, H1 2020
Myocardial Infarction - Pipeline by Silver Creek Pharmaceuticals Inc, H1 2020
Myocardial Infarction - Pipeline by SmartPharm Therapeutics Inc, H1 2020
Myocardial Infarction - Pipeline by Sorrento Therapeutics Inc, H1 2020
Myocardial Infarction - Pipeline by T&R Biofab Co Ltd, H1 2020
Myocardial Infarction - Pipeline by TaiGen Biotechnology Co Ltd, H1 2020
Myocardial Infarction - Pipeline by Takeda Pharmaceutical Co Ltd, H1 2020
Myocardial Infarction - Pipeline by Techfields Pharma Co Ltd, H1 2020
Myocardial Infarction - Pipeline by Thrombolytic Science International LLC, H1 2020
Myocardial Infarction - Pipeline by Translational Sciences Inc, H1 2020
Myocardial Infarction - Pipeline by Vaxil Bio Therapeutics Ltd, H1 2020
Myocardial Infarction - Pipeline by XBiotech Inc, H1 2020
Myocardial Infarction - Pipeline by Xcelthera INC, H1 2020
Myocardial Infarction - Pipeline by Yichang Humanwell Pharmaceutical Co Ltd, H1 2020
Myocardial Infarction - Pipeline by Yuyu Pharma Inc, H1 2020
Myocardial Infarction - Pipeline by Zensun (Shanghai) Sci & Tech Co Ltd, H1 2020
Myocardial Infarction - Dormant Projects, H1 2020
Myocardial Infarction - Dormant Projects, H1 2020 (Contd..1), H1 2020
Myocardial Infarction - Dormant Projects, H1 2020 (Contd..2), H1 2020
Myocardial Infarction - Dormant Projects, H1 2020 (Contd..3), H1 2020
Myocardial Infarction - Dormant Projects, H1 2020 (Contd..4), H1 2020
Myocardial Infarction - Dormant Projects, H1 2020 (Contd..5), H1 2020
Myocardial Infarction - Dormant Projects, H1 2020 (Contd..6), H1 2020
Myocardial Infarction - Dormant Projects, H1 2020 (Contd..7), H1 2020
Myocardial Infarction - Dormant Projects, H1 2020 (Contd..8), H1 2020
Myocardial Infarction - Discontinued Products, H1 2020

List of Figures
Number of Products under Development for Myocardial Infarction, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Number of Products by Top 10 Targets, H1 2020
Number of Products by Stage and Top 10 Targets, H1 2020
Number of Products by Top 10 Mechanism of Actions, H1 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020
Number of Products by Top 10 Routes of Administration, H1 2020
Number of Products by Stage and Top 10 Routes of Administration, H1 2020
Number of Products by Top 10 Molecule Types, H1 2020
Number of Products by Stage and Top 10 Molecule Types, H1 2020

Companies Mentioned
• Actinogen Medical Ltd
• Angion Biomedica Corp
• Ankasa Regenerative Therapeutics Inc
• Aposcience AG
• Applied Therapeutics Inc
• Aprogen Inc
• APT Therapeutics Inc
• AstraZeneca Plc
• Athera Biotechnologies AB
• Athersys Inc
• Axolo Pharma Inc
• Bayer AG
• Bharat Biotech Ltd
• Cadila Healthcare Ltd
• CardioCreate Inc
• Cardiol Therapeutics Inc
• Cardior Pharmaceuticals GmbH
• CeleCor Therapeutics Inc
• Celixir Ltd
• CellProthera SAS
• CFM Pharma Holding BV
• Cynata Therapeutics Ltd
• Diffusion Pharmaceuticals Inc
• Domainex Ltd
• EndoProtech Inc
• Ever Supreme Bio Technology Co Ltd
• Evotec SE
• EyeGene Inc
• Faraday Pharmaceuticals Inc
• General Regeneratives Shanghai Ltd
• Generium
• GNT Pharma Co Ltd
• Hemostemix Inc
• Honya Medical Inc
• HUYA Bioscience International LLC
• Idorsia Pharmaceutical Ltd
• iHeart Japan Corp
• InCarda Therapeutics Inc
• Innolife Co Ltd
• Inotrem SA
• IPS Heart Inc
• K-Stemcell Co Ltd
• Kine Sciences
• Lee’s Pharmaceutical